In fact, a fundamental role of type 1 and type 2 interferon signaling in modulating response to endotoxin and endotoxin tolerance has been reported, including a clinical trial using IFNg to mitigate immune paralysis in sepsis (41, 48–51). This evidence concerns the gene SGCG and Sepsis.